Tetanus Severity Score for Prediction of Mortality in Manifest Tetanus

计划入组 115 人 · 首次发布于 2026 年 4 月 6 日

Early Manifest Glaucoma Trial (EMGT)

首次发布于 1999 年 9 月 24 日

IO Vancomycin Spine

计划入组 30 人 · 首次发布于 2024 年 12 月 27 日

IO-120/ IO-103 (IO Biotech)

IO-103;IO-120

IO-120 + IO-103

IO Biotech

Denmark

IO Biotech ApS

Denmark

NextCure

United States

MANIFEST IO Launches Landmark UK-Wide Prospective Study to Unravel Immunotherapy Response and Toxicity

Comparing Long-Term Data for IO/IO and IO/TKI in Favorable-Risk Metastatic Renal Cell Carcinoma

Nivolumab Plus Ipilimumab Shows Durable Survival Benefit in Advanced RCC